Biotechnology Value Fund is a private equity firm and venture debt provider. Team members are concentrated in San Francisco, California, United States. The known portfolio counts 17 companies, including Ambrosia Biosciences, Crossbow Therapeutics, Palvella Therapeutics, Expedition Therapeutics, Verastem Oncology and Numab.
Is Biotechnology Value Fund a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- BiotechDrug DiscoveryEvergreen FundGenomicsPharmaValue Investing
Contacts
Who to pitch at Biotechnology Value Fund
Biotechnology Value Fund portfolio companies (17)
- Ambrosia Biosciences
- Crossbow Therapeutics
- Palvella Therapeutics
- Expedition Therapeutics
- Verastem Oncology
- Numab
- Rapt Therapeutics
- Septerna
- Cidara Therapeutics
- Merida Biosciences
- Olema Oncology
- Alpha9 Theranostics
- Ikena Oncology
- Quanta Therapeutics
- Unicycive Therapeutics
- AC Immune
- Delcath Systems
Co-investors
Funds that share portfolio companies with Biotechnology Value Fund.
Similar funds
Showing 20 of 100
About Biotechnology Value Fund
The firm's listing covers sector Healthcare, and focus areas Biotech, Drug Discovery, Evergreen Fund and Genomics; known deals cluster at Growth, Late-Stage and Seed.
The contacts to approach at Biotechnology Value Fund are Thor Nagel (Bvf Partners, L.P) and Iris van Alderwerelt van Rosenburgh (Bvf Partners, L.P).
Biotechnology Value Fund shares portfolio companies with 20 other investment firms, among them Octagon Capital Advisors, MiraeAsset Financial Group and Merck.
Frequently asked questions
What is Biotechnology Value Fund?
Biotechnology Value Fund is a private equity firm and venture debt provider whose team is concentrated in San Francisco, California, United States, with a known portfolio of 17 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does Biotechnology Value Fund invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Drug Discovery, Evergreen Fund and Genomics. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does Biotechnology Value Fund invest at?
The known deals of Biotechnology Value Fund include Growth, Late-Stage and Seed rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
Who should I pitch at Biotechnology Value Fund?
Both people on file at Biotechnology Value Fund are listed as contacts for the firm, each with their own profile page.
How do I contact Biotechnology Value Fund?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 2 people attached to the firm have their own pages, each showing whether an address is on file for them.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal